The title compound N-（（3-（2-nitrophenyl） propanoyl）oxy）-N-phenylbenzamide（C22H18N2O5,Mr = 390.38） was synthesized with nitrobenzene as the starting materials and structurally characterized by 1H NMR,13 C NMR,I...The title compound N-（（3-（2-nitrophenyl） propanoyl）oxy）-N-phenylbenzamide（C22H18N2O5,Mr = 390.38） was synthesized with nitrobenzene as the starting materials and structurally characterized by 1H NMR,13 C NMR,IR,H RMS（E-SI） and single-crystal X-ray diffraction.The crystalline structure of the title compound was studied in detail.The single-crystal X-ray diffraction revealed that the compound crystallizes in monoclinic,space group P21/n,with a = 14.4481（7）,b = 8.0089（5）,c = 16.6808（9） A,α = 90.00（5）,β = 100.069（5）,γ = 90.00（5）°,Mr = 390.38,V = 1900.46（18） A^3,Z = 4,Dc = 1.364 g/cm^-3,μ = 0.098,F（000） = 816.0,the final R = 0.0530 and w R = 0.1141 for 2525 observed reflections（I 〉 2σ（I））,R（all data） = 0.0813,w R（all data） = 0.1335,completeness to theta of 26.020 is 99.8% and GOF = 1.085.The crystal structure contains three branched chains with its center placed at the midpoint of N.The phenyl ring（C（8）~C（13）） makes a dihedral angle of 83.5（1） ℃ with the phenyl ring（C（1）~C（6））,and 80.5（1） ℃with the nitro-substituted benzene ring（C（17）~C（22））,indicating that the three rings are not coplanar.Hydrogen bonds（C（10）–H（10）···O（3））,（C（15）–H（15B）···O（4） and C（16）–H（16B）···O（4）） together with π-π stacking interactions stabilize the structure of the molecule.The preliminary biological test shows that the title compound has good antitumor activity against A549 in vitro with the IC50 value of 3.17 μmol.展开更多
基金Supported by the Lanzhou Science and Technology Bureau Program Funds(2013-4-79,2014-1-174,2014-1-214)
文摘The title compound N-（（3-（2-nitrophenyl） propanoyl）oxy）-N-phenylbenzamide（C22H18N2O5,Mr = 390.38） was synthesized with nitrobenzene as the starting materials and structurally characterized by 1H NMR,13 C NMR,IR,H RMS（E-SI） and single-crystal X-ray diffraction.The crystalline structure of the title compound was studied in detail.The single-crystal X-ray diffraction revealed that the compound crystallizes in monoclinic,space group P21/n,with a = 14.4481（7）,b = 8.0089（5）,c = 16.6808（9） A,α = 90.00（5）,β = 100.069（5）,γ = 90.00（5）°,Mr = 390.38,V = 1900.46（18） A^3,Z = 4,Dc = 1.364 g/cm^-3,μ = 0.098,F（000） = 816.0,the final R = 0.0530 and w R = 0.1141 for 2525 observed reflections（I 〉 2σ（I））,R（all data） = 0.0813,w R（all data） = 0.1335,completeness to theta of 26.020 is 99.8% and GOF = 1.085.The crystal structure contains three branched chains with its center placed at the midpoint of N.The phenyl ring（C（8）~C（13）） makes a dihedral angle of 83.5（1） ℃ with the phenyl ring（C（1）~C（6））,and 80.5（1） ℃with the nitro-substituted benzene ring（C（17）~C（22））,indicating that the three rings are not coplanar.Hydrogen bonds（C（10）–H（10）···O（3））,（C（15）–H（15B）···O（4） and C（16）–H（16B）···O（4）） together with π-π stacking interactions stabilize the structure of the molecule.The preliminary biological test shows that the title compound has good antitumor activity against A549 in vitro with the IC50 value of 3.17 μmol.
